Lung cancer is no longer solely a smoker’s disease, with air pollution emerging as a significant risk factor affecting non-smokers. Early screening is crucial as symptoms are often mistaken for common ailments, leading to delayed diagnosis. Personalized treatments and new-age therapies like immunotherapy are improving outcomes and quality of life for patients.
